Transfusions and blood loss in total hip and knee arthroplasty: A prospective observational study

Journal of Orthopaedic Surgery and Research

Volumn 10, Issue 1, 2015, Pages

  Carling, Malin S ^a,b   Jeppsson, Anders ^a,b   Eriksson, Bengt I ^a,b   Brisby, Helena ^a,b  

^a SAHLGRENSKA UNIVERSITY HOSPITAL   (Sweden)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

Author keywords

Arthroplasty; Hemorrhage; Transfusion

Indexed keywords

ANTIFIBRINOLYTIC AGENT; TRANEXAMIC ACID;

AGED; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; ELECTIVE SURGERY; FEMALE; HIP REPLACEMENT; HUMAN; KNEE REPLACEMENT; MALE; MIDDLE AGED; PROSPECTIVE STUDY; STATISTICS AND NUMERICAL DATA;

AGED; ANTIFIBRINOLYTIC AGENTS; ARTHROPLASTY, REPLACEMENT, HIP; ARTHROPLASTY, REPLACEMENT, KNEE; BLOOD LOSS, SURGICAL; BLOOD TRANSFUSION; ELECTIVE SURGICAL PROCEDURES; FEMALE; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; TRANEXAMIC ACID;

EID: 84926282653     PISSN: None     EISSN: 1749799X     Source Type: Journal    
DOI: 10.1186/s13018-015-0188-6     Document Type: Article

References (35)

1. Rosencher N, Kerkkamp HE, Macheras G, Munuera LM, Menichella G, Barton DM, et al. Orthopedic Surgery Transfusion Hemoglobin European Overview (OSTHEO) study: blood management in elective knee and hip arthroplasty in Europe. Transfusion. 2003;43:459-69.
2. Vuille-Lessard É, Boudreault D, Girard F, Ruel M, Chagnon M, Hardy J-F. Red blood cell transfusion practice in elective orthopedic surgery: a multicenter cohort study. Transfusion. 2010;50:2117-24.
3. Stanworth SJ, Cockburn HAC, Boralessa H, Contreras M. Which groups of patients are transfused? A study of red cell usage in London and southeast England. Vox Sang. 2002;83:352-7.
4. Jans O, Kehlet H, Hussain Z, Johansson PI. Transfusion practice in hip arthroplasty - a nationwide study. Vox Sang. 2011;100:374-80.
5. Browne JA, Adib F, Brown TE, Novicoff WM. Transfusion rates are increasing following total hip arthroplasty: risk factors and outcomes. J Arthroplasty. 2013;28 Suppl 8:34-7.
6. Spiess BD. Transfusion of blood products affects outcome in cardiac surgery. Semin Cardiothor Vasc Anesth. 2004;8:267-81.
7. Rawn J. The silent risks of blood transfusion. Curr Opin Anaesth. 2008;21:664-8.
8. Surgenor SD, Kramer RS, Olmstead EM, Ross CS, Sellke FW, Likosky DS, et al. The association of perioperative red blood cell transfusions and decreased long-term survival after cardiac surgery. Anesth Analg. 2009;108:1741-6.
9. Koch CG, Li L, Duncan AI, Mihaljevic T, Cosgrove DM, Loop FD, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34:1608-16.
10. Perisanidis C, Mittlböck M, Dettke M, Schopper C, Schoppmann A, Kostakis GC, et al. Identifying risk factors for allogenic blood transfusion in oral and oropharyngeal cancer surgery with free flap reconstruction. J Oral Maxillofac Surg. 2013;71:798-804.
11. Park JH, Rasouli MR, Mortazavi SMJ, Tokarski AT, Maltenfort MG, Parvizi J. Predictors of perioperative blood loss in total joint arthroplasty. J Bone Joint Surg Am. 2013;95:1777-83.
12. Brecher ME, Monk T, Goodnough LT. A standardized method for calculating blood loss. Transfusion. 1997;37:1070-4.
13. Sehat KR, Evans RL, Newman JH. Hidden blood loss following hip and knee arthroplasty: correct management of blood loss should take hidden loss into account. J Bone Joint Surg (Br). 2004;86:561-5.
14. Ledin H, Aspenberg P, Good L. Tourniquet use in total knee replacement does not improve fixation, but appears to reduce final range of motion. Acta Orthop. 2012;83:499-503.
15. Tetro AM, Rudan JF. The effects of a pneumatic tourniquet on blood loss in total knee arthroplasty. Can J Surg. 2001;44:33-8.
16. Liu X, Zhang X, Chen Y, Wang Q, Jiang Y, Zeng B. Hidden blood loss after total hip arthroplasty. J Arthroplasty. 2011;26:1100-5.
17. Karthik S, Grayson AD, McCarron EE, Pullan DM, Desmond MJ. Reexploration for bleeding after coronary artery bypass surgery: risk factors, outcomes, and the effect of time delay. Ann Thorac Surg. 2004;78:527-34.
18. Prasad N, Padmanabhan V, Mullaji A. Blood loss in total knee arthroplasty: an analysis of risk factors. Int Orthop. 2007;31:39-44.
19. Hrnack SA, Skeen N, Xu T, Rosenstein AD. Correlation of body mass index and blood loss during total knee and total hip arthroplasty. Am J Orthop. 2012;41:467-71.
20. Bowditch MG, Villar RN. Do obese patients bleed more? A prospective study of blood loss at total hip replacement. Ann R Coll Surg Engl. 1999;81:198-200.
21. Walsh M, Preston C, Bong M, Patel V, Di Cesare PE. Relative risk factors for requirement of blood transfusion after total hip arthroplasty. J Arthroplasty. 2007;22:1162-7.
22. Bong MR, Patel V, Chang E, Issack PS, Hebert R, Di Cesare PE. Risks associated with blood transfusion after total knee arthroplasty. J Arthroplasty. 2004;19:281-7.
23. Capraro L. Transfusion practices in primary total joint replacements in Finland. Vox Sang. 1998;75:1-6.
24. Borghi B, Casati A. Incidence and risk factors for allogenic blood transfusion during major joint replacement using an integrated autotransfusion regimen. Eur J Anaesthesiol. 2000;17:411-7.
25. So-Osman C, Nelissen R, Brand R, Faber F, Slaa RT, Stiggelbout A, et al. The impact of a restrictive transfusion trigger on post-operative complication rate and well-being following elective orthopaedic surgery: a post-hoc analysis of a randomised study. Blood Transfus. 2013;11:289-95.
26. Robinson PM, Obi N, Harison T, Jeffery J. Changing transfusion practice in total hip arthroplasty: observational study of the reduction of blood use over 6 years. Orthopedics. 2012;35:e1586-91.
27. Hatzidakis AM, Mendlick RM, McKillip T, Reddy RL, Garvin KL. Preoperative autologous donation for total joint arthroplasty: an analysis of risk factors for allogenic transfusion. J Bone Joint Surg Am. 2000;82:89-100.
28. Barr PJ, Donnelly M, Cardwell C, Alam SS, Morris K, Parker M, et al. Drivers of transfusion decision making and quality of the evidence in orthopedic surgery: a systematic review of the literature. Transfus Med Rev. 2011;25:304-16.
29. Guerin S, Collins C, Kapoor H, McClean I, Collins D. Blood transfusion requirement prediction in patients undergoing primary total hip and knee arthroplasty. Transfus Med. 2007;17:37-43.
30. Mesa-Ramos F, Mesa-Ramos M, Maquieira-Canosa C, Carpintero P. Predictors for blood transfusion following total knee arthroplasty: a prospective randomised study. Acta Orthop Belg. 2008;74:83-9.
31. Spahn DR. Anemia and patient blood management in hip and knee surgery: a systematic review of the literature. Anesthesiology. 2010;113:482-95.
32. Martinez V, Monsaingeon-Lion A, Cherif K, Judet T, Chauvin M, Fletcher D. Transfusion strategy for primary knee and hip arthroplasty: impact of an algorithm to lower transfusion rates and hospital costs. Br J Anaesth. 2007;99:794-800.
33. Carless PA, Henry DA, Moxey AJ, O'Connell D, Brown T, Fergusson DA. Cell salvage for minimising perioperative allogeneic blood transfusion. Cochrane Database Syst Rev. 2010;14(4):CD001888.
34. Boralessa H, Goldhill DR, Tucker K, Mortimer AJ, Grant-Casey J. National comparative audit of blood use in elective primary unilateral total hip replacement surgery in the UK. Ann R Coll Surg Engl. 2009;91:599-605.
35. Ker K, Edwards P, Perel P, Shakur H, Roberts I. Effect of tranexamic acid on surgical bleeding: systematic review and cumulative meta-analysis. BMJ. 2012;344:e3054.